Comparison of lung preservation solutions in human lungs using an ex vivo lung perfusion experimental model

Clinics

Volumn 67, Issue 9, 2012, Pages 1101-1106

  Medeiros, Israel L ^a   Pêgo Fernandes, Paulo M ^a   Mariani, Alessandro W ^a   Fernandes, Flávio G ^a   Unterpertinger, Fernando V ^a   Canzian, Mauro ^a   Jatene, Fabio B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ischemia Reperfusion Injury; Lung Transplantation; Organ Preservation

Indexed keywords

CITRIC ACID; PERFADEX; PRESERVATION SOLUTION;

ADULT; ARTICLE; CELL COUNT; CHEMISTRY; COLD ISCHEMIA; DONOR; FLUORESCENCE; HUMAN; LUNG; METHODOLOGY; MIDDLE AGED; ORGAN PRESERVATION; PATHOLOGY; PERFUSION; REPERFUSION INJURY; TIME;

ADULT; CELL COUNT; CITRATES; COLD ISCHEMIA; FLUORESCENCE; HUMANS; LUNG; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PERFUSION; REPERFUSION INJURY; TIME FACTORS; TISSUE DONORS;

EID: 84867185524     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(09)19     Document Type: Article

References (15)

1. de Perrot M, Keshavjee S. Lung preservation. Chest Surg Clin N Am. 2003;13(3):443-62, http://dx.doi.org/10.1016/S1052-3359(03)00055-3.
2. Maccherini M, Keshafjee SH, Slutsky AS, Patterson GA, Edelson JD. The effect of low-potassium dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes. Transplantation. 1991;52(4):621-6, http://dx.doi.org/10.1097/00007890-199110000-00008.
3. Bins OAR, DeLima NF, Buchanan SA, Cope JT, King RC, Marek CA, et al. Both blood and crystalloid-based extracellular solutions are superior to intracellular solutions for lung preservation. J Thorac Cardiovasc Surg. 1996;112(6):1515-21, http://dx.doi.org/10.1016/S0022-5223(96)70010-7.
4. Strüber M, Hohlfeld JM, Fraund S, Kim P, Warnecke G, Haverich A. Low-potassium-dextran solution ameliorates reperfusion injury of the lung and protects surfactant function. J Thorac Cardiovasc Surg. 2000;120(3):566-72, http://dx.doi.org/10.1067/mtc.2000.107831.
5. Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357(9259):825-9, http://dx.doi.org/10.1016/S0140-6736(00)04195-7.
6. Steen S, Liao Q, Wierup PN, Bolys R, Pierre L, Sjöberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg. 2003;76(1):244-52; discussion 252, http:// dx.doi.org/10.1016/S0003-4975(03)00191-7.
7. Steen S, Ingemansson R, Eriksson L, Pierre L, Algotsson L, Wierup P, et al. First human transplantation of a nonaccepTable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83(6):2191-4, http:// dx.doi.org/10.1016/j.athoracsur.2007.01.033.
8. Pego-Fernandes PM, Medeiros IL, Mariani AW, Fernandes FG, Unterpertinger FV, Samano MN, et al. Ex vivo lung perfusion: early report of brazilian experience. Transplant Proc. 2010;42(2):440-3, http:// dx.doi.org/10.1016/j.transproceed.2010.01.015.
9. Aigner C, Seebacher G, Klepetko W. Donor selection. Chest Surg Clin N Am. 2003;13(3):429-42, http://dx.doi.org/10.1016/S1052-3359(03) 00051-6.
10. Keshafjee SH, Yamazaki F, Cardoso PF, McRitchie DI, Patterson GA, Cooper JD. A method for safe twelve-hour pulmonary preservation. J Thorac Cardiovasc Surg. 1989;98(4):529-34.
11. Steen S, Kimblad PO, Sjöberg T, Lindberg L, Ingemansson R, Massa G. Safe lung preservation for twenty-four hours with Perfadex. Ann Thorac Surg. 1994;57(2):450-7, http://dx.doi.org/10.1016/0003-4975(94)91016-2.
12. Sommer SP, Warnecke G, Hohlfeld JM, Gohrbandt B, Niedermeyer J, Kofidis T, et al. Pulmonary preservation with LPD and Celsior solution in porcine lung transplantation after 24 h of cold ischemia. Eur J Cardiothorac Surg. 2004;26(1):151-7.
13. Egan TM, Haithcock JA, Nicotra WA, Koukoulis G, Inokawa H, Sevala M, et al. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg. 2006;81(4):1205-13, http://dx.doi.org/10.1016/ j.athoracsur.2005.09.034.
14. Cypel M, Rubacha M, Yeung J, Hirayama S, Torbicki K, Madonik M, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant. 2009;9(10):2262-9.
15. Soares PRO, Braga KAO, Nepomuceno NA, Pazetti R, Correia AT, Cardoso PFG, et al. Comparison between Perfadex and locally manufactured low-potassium dextran solution for pulmonary preservation in an ex vivo isolated lung perfusion model. Transplant Proc. 2011;43(1):84-8, http://dx.doi.org/10.1016/j.transproceed.2010.12.005.